Antibody drug conjugates against the receptor for advanced glycation end products (RAGE), a novel therapeutic target in endometrial cancer
- Submitting institution
-
Swansea University / Prifysgol Abertawe
- Unit of assessment
- 3 - Allied Health Professions, Dentistry, Nursing and Pharmacy
- Output identifier
- 52619
- Type
- D - Journal article
- DOI
-
10.1186/s40425-019-0765-z
- Title of journal
- Journal for ImmunoTherapy of Cancer
- Article number
- 280
- First page
- -
- Volume
- 7
- Issue
- 1
- ISSN
- 2051-1426
- Open access status
- Compliant
- Month of publication
- October
- Year of publication
- 2019
- URL
-
-
- Supplementary information
-
-
- Request cross-referral to
- -
- Output has been delayed by COVID-19
- No
- COVID-19 affected output statement
- -
- Forensic science
- No
- Criminology
- No
- Interdisciplinary
- No
- Number of additional authors
-
17
- Research group(s)
-
1 - Biomarkers and Genes
- Citation count
- -
- Proposed double-weighted
- No
- Reserve for an output with double weighting
- No
- Additional information
- -
- Author contribution statement
- The author conceived the study, contributed to the experimental design and the preparation of the manuscript.
- Non-English
- No
- English abstract
- -